Related Experiment Video
Updated: Mar 31, 2026

mirMachine: A One-Stop Shop for Plant miRNA Annotation
Published on: May 1, 2021
The role of miRNAs in cutaneous squamous cell carcinoma
1Department of Orthopaedic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Abstract:
MicroRNAs (miRs) are small, noncoding RNAs that negatively regulate gene expressions at posttranscriptional level. Each miR can control hundreds of gene targets and play important roles in various biological and pathological processes such as hematopoiesis, organogenesis, cell apoptosis and proliferation. Aberrant miR expression contributes to initiation and cell progression of cancers. Accumulating studies have found that miRs play a significant role in cutaneous squamous cell carcinoma (cSCC). Deregulations of miRs may contribute to cSCC carcinogenesis is through acting as oncogenic or tumour suppressive miRs. In this study, we summarized the recent data available on cSCC-associated miRs. In particular, we will discuss the contribution of miR to the initiation and progression of cSCCs. Although there are many obstacles to be overcome, clinical use of miRs as biomarkers for diagnosis, prediction of prognosis and target for therapies, will be a promising area in the future with more expression and functional role of miRs revealed.
Insights
MicroRNAs (miRs) are key regulators in cancer. This study reviews their role in cutaneous squamous cell carcinoma (cSCC), highlighting their potential as diagnostic biomarkers and therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRs) are small, noncoding RNAs regulating gene expression post-transcriptionally.
- Aberrant miR expression is implicated in cancer initiation and progression.
- miRs play significant roles in various biological processes, including cell apoptosis and proliferation.
Purpose of the Study:
- To summarize current data on microRNAs associated with cutaneous squamous cell carcinoma (cSCC).
- To discuss the contribution of miRs to cSCC initiation and progression.
- To explore the future clinical potential of miRs in cSCC diagnosis, prognosis, and therapy.
Main Methods:
- Literature review and data summarization.
- Analysis of existing studies on miR expression in cSCC.
- Discussion of oncogenic and tumor-suppressive roles of miRs in cSCC.
Main Results:
- miRs are significantly deregulated in cSCC, acting as oncogenic or tumor-suppressive molecules.
- Specific miRs contribute to the initiation and progression of cSCC.
- miRs have demonstrated potential in regulating key cellular processes relevant to cSCC.
Conclusions:
- miRs are crucial in cSCC pathogenesis.
- Further research into miR expression and function will advance cSCC understanding.
- Clinical applications of miRs as biomarkers and therapeutic targets in cSCC are promising.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

